Certified by Founder Lodge 
                                        
                                        Ensoma
 
                                                 United States  -  Boston, MA 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $85,000,000
                                            0 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            At Ensoma, we develop one-time in vivo treatments that precisely engineer any or all blood and immune cells to cure diseases from within.
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| February, 06 ,2023 | Series B | $85,000,000 | |
| May, 17 ,2023 | Series B | $50,000,000.00 | 
                                                
 Qatar Investment Authority
                                                                                
                                                                            
 Alexandria Real Estate Equities, Inc.
                                                                                
 F-Prime Capital
                                                                                
 Viking Global Investors
                                                                                
 5AM Ventures
                                                                                
 Catalio Capital Management
                                                                                
 Arix Bioscience plc
                                                                                
                                                                            
 Takeda Ventures, Inc.
                                                                                
 Bill & Melinda Gates Foundation
                                                                                
 Solasta Ventures
                                                                                
 Mirae Asset Global Investments
                                                                                
                                                                            
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
 
                                            
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)